Anzeige
❌
Mehr »
Samstag, 21.11.2026 - Börsentäglich über 12.000 News
Zufall oder Strategie? Copper One zündet die nächste Stufe seiner Kupfer-Offensive!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 850103 | ISIN: US0028241000 | Ticker: ABL
Tradegate
20.11.26 | 21:45
93,98 Euro
-0,11 % -0,10
Branche
Pharma
Aktienmarkt
USA All 500
USA 100
1-Jahres-Chart
ABBOTT LABORATORIES Chart 1 Jahr
5-Tage-Chart
ABBOTT LABORATORIES 5-Tage-Chart
RealtimeGeldBriefZeit
93,6294,2013:05
93,9094,3220.11.

Aktuelle News zur ABBOTT LABORATORIES Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DoAbbott launches clinical trial for software-guided balloon-expandable TAVI system3
DoMedTech poised to outperform in 2027, Leerink says as Abbott upgraded6
DoAbbott initiates trial for Encantor heart valve system3
DoAbbott initiates VOYAGER clinical trial for investigational Encantor software-guided balloon-expandable TAVI system to treat aortic stenosis204Abbott's Encantor system includes software-guided deployment technology designed to help optimize valve expansion to the patient's unique anatomy, supporting precise implantation and consistent valve...
► Artikel lesen
DoThis Abbott Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday3
ABBOTT LABORATORIES Aktie jetzt für 0€ handeln
MoDividendenbekanntmachungen (16.11.2026)10.017 Unternehmen  ISIN-Code  Dividende (Währung)  Dividende (EUR)  ABBOTT LABORATORIES  US0028241000  0,63 USD   EUR  ABBVIE INC  US00287Y1091  1,73 USD   EUR  AGCO CORPORATION  US0010841023  0,3 USD  0...
► Artikel lesen
MoHere's How Abbott's EP Business Is Shaping Up for the Rest of 202620
11.11.Abbott nabs FDA approval, CE Mark for implantable cardioverter-defibrillator lead5
10.11.Abbott's conduction system pacing lead nets US, European approvals1
10.11.New Abbott Panbio COVID-19/Flu A&B Self-Test Helps Canadian Families Make Informed Decisions During Respiratory Illness Season3
10.11.What Are Wall Street Analysts' Target Price for Abbott Stock?6
04.11.ABBOTT LABORATORIES - 10-Q, Quarterly Report24
03.11.Abbott's Tectonic test looks to shift artery disease treatment with 'early' win6
03.11.Was der Markt bei bioMérieux übersah!
02.11.Abbott Touts Favorable Outcomes In Cardiovascular Device Trials13
02.11.Abbott's next-gen Amulet 360 LAA occluder delivers one-year data3
02.11.Abbott, J&J spotlight clinical successes in coronary intravascular lithotripsy5
02.11.Abbott Laboratories Amulet 360 Achieves 98% Stroke-Free Rate In VERITAS Study833NORTH CHICAGO (dpa-AFX) - Monday, Abbott Laboratories (ABT) announced one-year results for its investigational Amulet 360 Left Atrial Appendage Occluder from the VERITAS study, evaluating the...
► Artikel lesen
02.11.Late-breaking one-year data show Abbott's next-generation Amulet 360 device continues to demonstrate high rates of left atrial appendage closure and low incidence of stroke348Late-breaking one-year VERITAS study results were presented at the Transcatheter Cardiovascular Therapeutics conference and simultaneously published in JACC: Cardiovascular Interventions; data show...
► Artikel lesen
01.11.Abbott's TECTONIC clinical trial demonstrates strong 30-day outcomes and high procedural success for its investigational SonicForce Coronary Intravascular Lithotripsy System379SonicForce is an investigational coronary intravascular lithotripsy (IVL) system that uses acoustic pressure waves, similar to those used to break up kidney stones, to crack calcium in coronary arteries...
► Artikel lesen
1 2 3 4 5 Weiter >>
301 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,4